Entry Detail



General Information

Database ID:exR0354711
RNA Name:hsa-miR-541-3p
RNA Type:miRNA
Chromosome:chr14
Starnd:+
Coordinate:
Start Site(bp):101064548End Site(bp):101064569
External Links:hsa-miR-541-3p



Disease Information

Disease Name:Glioblastoma Multiforme
Disease Category:Cancers
MeSH ID:D005909
Type:Neoplasms/Neoplasms, Glandular and Epithelial
Alias:Glioblastoma//Glioblastomas//Astrocytoma, Grade IV//Astrocytomas, Grade IV//Grade IV Astrocytoma//Grade IV Astrocytomas//Glioblastoma Multiforme//Giant Cell Glioblastoma//Giant Cell Glioblastomas//Glioblastoma, Giant Cell//Glioblastomas, Giant Cell



Expression Detail

GEO ID:GSE93850
Description:Serum miRNAs in Patients with Glioblastoma Multiforme
Experimental Design:Cancer vs Control
Case Disease Type:Glioblastoma Multiforme
Case Disease SubType:NA
Case Sample:Glioblastoma Multiforme
Control Sample:Healthy
Number of Case:22
Number of Control:8
Number of Samples:30





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
REPIN1
chr7
150368189
150374044
+
HOXD11
chr2
176104216
176109754
+
LY6E
chr8
143017982
143023832
+
FASN
chr17
82078338
82098294
-
M6PR
chr12
8940361
8949761
-
TOM1L2
chr17
17843511
17972422
-
ACACA
chr17
37084992
37406836
-
TAF4
chr20
61953469
62065810
-
MID1IP1
chrX
38801432
38806537
+
FBXO46
chr19
45710629
45730896
-
BICRA
chr19
47608196
47703277
+
CALR
chr19
12938578
12944489
+
ARHGDIA
chr17
81867721
81871378
-
UCP2
chr11
73974672
73983246
-
FKBP1A
chr20
1368978
1393172
-
SLC6A6
chr3
14402576
14489349
+
NFIX
chr19
12995608
13098796
+
ADGRL1
chr19
14147743
14206187
-
NID1
chr1
235975830
236065109
-
CAPZB
chr1
19338775
19485539
-
AGRN
chr1
1020120
1056118
+
AXL
chr19
41219223
41261766
+
MAFG
chr17
81918270
81927735
-
PKM
chr15
72199029
72231822
-
IGFBP5
chr2
216672105
216695549
-
MIGA2
chr9
129036621
129072082
+
ZMIZ1
chr10
79068966
79316528
+
PRRC2B
chr9
131373636
131500197
+
ACVR1B
chr12
51951699
51997078
+
DMWD
chr19
45782947
45792845
-
miRNA targets:NA
circRNA targets:
circRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa_circ_0000417
chr12
69644908
69656342
+
hsa_circ_0000642
chr15
80390757
80415142
+
hsa_circ_0000816
chr17
80521229
80526077
+
hsa_circ_0000643
chr15
80412669
80415142
+
hsa_circ_0000943
chr19
47421744
47440665
+
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC239868.1
chr1
149861271
149862504
+
AL035458.2
chr20
34234840
34281173
-
AL356488.2
chr1
109100193
109100619
+
NEAT1
chr11
65422774
65445540
+
NORAD
chr20
36045618
36051018
-
OIP5-AS1
chr15
41283990
41309737
+
STAG3L5P-PVRIG2P-PILRB
chr7
100336104
100367831
+
XIST
chrX
73820649
73852723
-
Display:



Experiment Detail

GEO ID:GSE93850
Sample Source:Blood
Source Fraction:Serum
Platform:GPL22948
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:1032
Sample treatment protocol:NA
RNA Extract protocol:Serum total RNA was isolated from serum samples using the Plasma/Serum Circulating and Exosomal RNA Purification Mini Kit (Slurry Format) (Norgen Biotek Corporation, Thorold, Ontario, Canada)
RNA library preparation protocol:0.3ug of total RNA of intrahepatic cholangiocarcinoma/normal intrahepatic bile duct tissue was employed with 100 nmol/L of pCp-DY547 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 ul at 16°C overnight.



Reference

PMID:28931080
Title:Low serum level of miR-485-3p predicts poor survival in patients with glioblastoma
Author:Wang ZQ, Zhang MY, Deng ML, Weng NQ, Wang HY,Wu SX
Journal:PLoS One. 2017 Sep 20;12(9):e0184969.
Description:we investigated whether 3 of the 19 miRNAs in serum could be used as prognostic biomarkers for patients with GBM.